Serum iron levels as a new biomarker in chemotherapy with leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan, with or without molecularly-targeted drugs

Serum iron levels have been reported to increase following the administration of various anticancer drugs. An increase in serum iron levels during therapy with leucovorin and fluorouracil plus oxaliplatin (FOLFOX) or leucovorin and fluorouracil plus irinotecan (FOLFIRI) was also observed. The aim of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: OCHIAI, TAKUMI, NISHIMURA, KAZUHIKO, WATANABE, TOMOO, KITAJIMA, MASAYUKI, NAKATANI, AKINORI, INOU, TAKASHI, SHIBATA, HIDEKI, SATO, TSUYOSHI, KISHINE, KENJI, SEO, SHOUGO, OKUBO, SATOSHI, FUTAGAWA, SHUNJI, MASHIKO, SATOMI, NAGAOKA, ISAO
Materialtyp: Artigo
Språk:Inglês
Publicerad: D.A. Spandidos 2013
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3916199/
https://ncbi.nlm.nih.gov/pubmed/24649250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2013.136
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk